Capitalising on opportunities
Innovative and well-managed companies in the healthcare sector can attract significant investor interest with the right advisors supporting them.
With offices in Europe, the US and Asia, our team has the global reach, industry knowledge and a great track record in delivering tailored solutions for the Healthcare sector.
"We have greatly appreciated Clearwater’s professionalism throughout this process. Their strong dedication generated several interesting and pertinent offers for our Groupe, and also reassured the shareholders, composed of founding members and practitioners.”
Alain foltzer, Managing Director 3H
The ageing population, rapid technological development, and increased demand for healthcare products and services are driving a buoyant healthcare market. Investment appetite in the sector from private equity and strategic investors is high.
Our team advises companies across the full spectrum of the healthcare ecosystem including:
- Health and social care
- Medical devices and disposable equipment
- Life sciences and pharma services
- Healthcare technology
We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution as they seek to consolidate and grow their global market positions. Our in-depth sector knowledge and extensive contacts, combined with our investment banking approach, enables us to help corporates and investors capitalise on the growing opportunities across the sector.
"We have greatly appreciated Clearwater’s professionalism throughout this process. Their strong dedication generated several interesting and pertinent offers for our Groupe, and also reassured the shareholders, composed of founding members and practitioners.”
Alain foltzer, Managing Director 3H
PROOF POINTS
Primary sector deals
86
in the last 5 years
Primary sector deal value
€11.1bn
in the last 5 years
Primary sector deals involving PE
62%
in the last 5 years
Choose a service
Our services are focused on maximising business potential through M&A and Debt Advisory. We are inherently objective in the advice we deliver because we don’t have other services to sell.
Insights
Through the lens of sector experts with decades of hands-on experience, our game-changing insights reveal things unseen by others; enhancing instead of replicating what you already know.
Transactions
Not just numbers on a balance sheet, our transactions represent over 20 years’ commitment to our clients’ future. Helping them change the game. Even before it was ready to be changed.
Clearwater advises Sanifarma on its sale to Fidia Farmaceutici
Adviser to Sanifarma on its sale to Fidia Farmaceutici
Clearwater ha asesorado a ATP Farma en la venta de una participación mayoritaria a Plameca
Clearwater advises Primonial REIM on the sale of the real estate of La Clinique du Parc to AEW
Adviser to PREIM on the sale of the real estate of Clinique du Parc to AEW
Clearwater advises i2i on its sale to IG&H
Adviser to i2i on its sale to IG&H